AI Develops Anti-Aging Drug

An American pharmaceutical company utilizing artificial intelligence in drug development has found that its own drug for treating pulmonary fibrosis, designed to improve patients' health, has the potential to reduce their biological age by approximately four years. This suggests a possible effect in reversing signs of aging. The study showed that the drug helped lower biological age measurements, although the research was limited by the lack of a broad control group and the absence of healthy participants, which prevents a definitive judgment on its overall anti-aging efficacy. While the results are promising, experts caution that these preliminary studies do not confirm aging as a treatable disease, and the understanding of aging processes remains a subject of debate. The drug is not considered a cure for aging itself.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل